Market scope covers commercially traded GLP-1-supportive foods sold across retail, e-commerce, direct-to-consumer, pharmacy-adjacent, and foodservice channels
Novo Nordisk brought in around $1.35 billion from Wegovy in the first quarter of 2024, while Eli Lillys Zepbound brought in over $517 million
These advances weaken one of the most frequently cited historical objections to peptide therapeutics and broaden the range of clinical contexts in which they can be realistically deployed
2023, doi: 10.1056/NEJMoa2307563
It's also worth mentioning that 11% of people on the placebo also experienced constipation
GLP-1 receptor agonists have gained attention for weight management during perimenopause, a metabolically complex transition affecting women typically in their 40s and early 50s